Highlights
A collection of news and information related to Celgene Corporation published by this site and its partners.
Displaying items 1-12 of 17
» View ky3.com items only
1
2
Next >
-
Wall St. slides as worry lingers over future of stimulus
ReutersNEW YORK (Reuters) - U.S. stocks fell on Wednesday, with the Dow sliding more than 100 points on another volatile day as traders extended a selloff driven by concern about central banks winding down their stimulus measures. The S&P 500 was caught between...Tags: Kentucky Fried Chicken, Prices, Computing and Information Technology Industry, American Express Company, Citigroup Incorporated
-
Celgene arthritis drug maintains efficacy at 52 weeks-study
ReutersBy Bill Berkrot June 11 (Reuters) - Celgene Corp's experimental drug for psoriatic arthritis maintained its ability to significantly reduce painful symptoms through 52 weeks of treatment, according to data from a late stage study being presented this...Tags: Biotechnology Industry, Placebo, Medical Research, Skin Conditions, Humira (drug)
-
Agios Pharmaceuticals files for IPO of up to $86 mln
ReutersJune 10 (Reuters) - Biopharmaceutical company Agios Pharmaceuticals Inc filed with U.S. regulators on Monday to raise up to $86 million in an initial public offering of common stock. The Cambridge, Massachusetts-based company told the U.S. Securities and...Tags: Financing and Stock Offerings, U.S. Securities and Exchange Commission, Physiology, Drugs and Medicines, Goldman Sachs Group, Inc.
-
EU backs Celgene, Aegerion drugs; sees no Lantus cancer risk
ReutersLONDON, May 31 (Reuters) - European regulators have recommended approval of a new drug from Celgene for patients with multiple myeloma whose disease has worsened after being treated with other cancer drugs. Friday's green light from the European...Tags: Drugs and Medicines, Lantus (drug)
-
U.S. RESEARCH ROUNDUP: Blackrock, CME Group, Morgan Stanley, Splunk
ReutersMay 31 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Blackrock and CME Group, on Friday. HIGHLIGHTS * U.S. Asset Managers: JP Morgan raises target on Blackrock, others * CME...Tags: CIT Group Incorporated, American Express Company, Myriad Genetics Incorporated, Petroleum Industry, Blackrock Inc
-
FACTBOX-U.S. biotech shares outpace broader stock market
ReutersMay 28 (Reuters) - Shares of biotechnology companies have outrun a bull market for U.S. stocks, rising nearly 50 percent over the past 12 months as investors look for new growth stories. Investors' enthusiasm, despite the inherent risk of drug...Tags: Biotechnology Industry, Amgen Inc., New Products, Prices, Cystic Fibrosis
-
ANALYSIS-Biotech's bull run starts to look frothy
ReutersBy Deena Beasley May 28 (Reuters) - Biotech stocks are so hot that even some of the bulls are starting to find themselves on edge. An index of biotech drugmakers' shares has climbed nearly 50 percent in the past 12 months to all-time highs as the...Tags: Gilead Sciences Inc., Rentals, Biotechnology Industry, Earnings, Amgen Inc.
-
MemorialCare Health System buys headquarters in Costa Mesa
Nonprofit medical provider MemorialCare Health System will move its headquarters from Fountain Valley to Costa Mesa because it has acquired a 15-acre corporate campus near the 405 Freeway. MemorialCare will consolidate several teams now in other Southern...
Tags: General Practitioners, Health and Medical Professionals, Realty, Health Insurance
-
L.A.'s richest man ups the ante for city, cancer fight
ReutersLOS ANGELES (Reuters) - As owner of 5 percent of the Los Angeles Lakers, Patrick Soon-Shiong could walk into the locker room of the storied basketball franchise any time for a chat with stars like Kobe Bryant. But the richest man in Los Angeles chooses to...Tags: Healthy Diet, Medical Research, Philip Anschutz, Verizon Communications, Diabetes
-
Myeloma Today
Staff reporterPlease join The Leukemia & Lymphoma Society for a patient program on myeloma on Wednesday, November 16th from 6 p.m. - 8 p.m. Dr. John Maciejewski, MD, PhD from Rush University Cancer Center will cover topics thatinclude an overview of Myeloma, such as...Tags: Chicago, Hospitals and Clinics, Millennium Pharmaceuticals Incorporated, Rush University Medical Center, Drugs and Medicines
Jun 12, 2013
|Story| Reuters
Jun 11, 2013
|Story| Reuters
Jun 10, 2013
|Story| Reuters
May 31, 2013
|Story| Reuters
May 31, 2013
|Story| Reuters
May 28, 2013
|Story| Reuters
May 28, 2013
|Story| Reuters
Feb 3, 2013
|Story| Los Angeles Times
Oct 3, 2012
|Story| Reuters
Nov 4, 2011
|Story| WGN-AM
Jul 23, 2006
|Story| Tribune Media Services
Dec 23, 2007
|Story| Tribune Media Services
Original site for Celgene Corporation topic gallery.